Fresenius Medical Care AG (FMCQF) Common Equity (2009 - 2026)

Fresenius Medical Care AG has reported Common Equity for 18 years, with the latest figure at $15.7 billion in Q2 2026.

• On a quarterly basis, Common Equity fell 3.02% year-over-year to $15.7 billion in Q2 2026; TTM through Jun 2026 was $15.7 billion, a 3.02% decrease from a year earlier, with the FY2025 full-year figure at $16.6 billion, down 1.33% from the prior year.
• Common Equity was $15.7 billion for Q2 2026 at Fresenius Medical Care AG, down from $16.6 billion in the prior quarter.
• The five-year high for Common Equity was $16.9 billion in Q3 2022, with the low at $15.7 billion in Q2 2026.
• Average Common Equity over 5 years is $16.4 billion, with a median of $16.3 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Common Equity gained 6.85% in 2022, then retreated 3.32% in 2024.
• Over 5 years, Common Equity stood at $15.8 billion in 2022, then advanced by 1.21% to $16.0 billion in 2023, then climbed by 5.63% to $16.9 billion in 2024, then decreased by 1.33% to $16.6 billion in 2025, then fell by 5.4% to $15.7 billion in 2026.
• The last three Common Equity figures came in at $15.7 billion (Q2 2026), $16.6 billion (Q1 2026), and $16.6 billion (Q4 2025), per Business Quant data.